tags

Chemical
PFAS
EU
PFAS Regulatory Wave: Compliance Challenges & Solutions for Medical Devices

Per- and Polyfluoroalkyl Substances (PFAS), commonly known as "forever chemicals", feature extremely stable carbon-fluorine bonds, high bioaccumulation potential and suspected endocrine disrupting properties, leading to stringent regulatory restrictions worldwide. According to OECD statistics, the PFAS family comprises over 10,000 substances. Fluoropolymers including Polytetrafluoroethylene (PTFE), FEP, PFA, PVDF and PCTFE are widely applied in cardiovascular catheters, implant coatings, pacemaker wire insulation, as well as sterile high-barrier packaging for medical devices.

ECHA Releases PFAS Draft Use Mapping

On November 5, 2025, the European Chemicals Agency (ECHA) published mapping of PFAS uses, serving as an industry support document for the upcoming public consultation on PFAS restrictions. The mapping systematically outlines PFAS applications across 14 major industrial, professional, and consumer sectors, including battery manufacturing, textiles, electronics, and PFAS production.

EU REACH Amendment Adds PFAS Control Provisions

On October 3, 2025, the European Commission published (EU) 2025/1988 in the Official Journal, amending Annex XVII of the REACH Regulation (Restrictions) to include item 82, which sets forth control requirements for PFAS in firefighting foams. The revised regulation will take effect on October 23, 2025. This amendment marks a significant step towards comprehensive PFAS regulation in the EU. The firefighting foam industry should pay close attention to this revision, and other industries should continue to monitor the EU's progress in regulating PFAS across all sectors.

ECHA Releases PFAS Restriction Proposal Assessment Timeline: Final Opinion Expected by 2026

On August 27, 2025, the European Chemicals Agency (ECHA) announced updated progress on the EU’s proposed "most stringent ever" restriction on per- and polyfluoroalkyl substances (PFAS). According to the latest timeline, the full scientific evaluation of the restriction proposal is expected to conclude by the end of 2026, paving the way for the European Commission to enact legislation that would comprehensively limit the production and use of over 10,000 PFAS chemicals. According to the latest timeline, the full scientific evaluation of the restriction proposal is expected to conclude by the end of 2026.

ECHA Releases Key Outcomes of March 2025 Meeting: Progress on PFAS Restriction Proposal

On March 19, 2025, The European Chemicals Agency (ECHA) announced significant advancements in chemical regulation following the first joint meeting of its Risk Assessment Committee (RAC) and Socio-Economic Analysis Committee (SEAC) in 2025. The committees reached multiple technical consensuses on key issues, including the proposed restriction of per- and polyfluoroalkyl substances (PFAS), marking a new phase in the EU’s chemical regulatory framework.